Certain restrictions apply; eligibility not based on income, must be 18 years of age or older. This offer is not valid for persons eligible for reimbursement of this product, in whole or in part under Medicaid, Medicare, or similar state or federal programs. Offer not valid for cash-paying patients. People who are not eligible can call 1-844-4OTEZLA to discuss other financial assistance opportunities.
VAS, visual analog scale.
RELIEF, Researching Oral Apremilast Safety and Efficacy in Behcet's Disease.
References: 1. Otezla [package insert]. Thousand Oaks, CA: Amgen Inc. 2. Data on file, Amgen Inc. 3. Hatemi G, Mahr A, Ishigatsubo Y, et al. Trial of Apremilast for oral ulcers in Behçet’s Syndrome. N Engl J Med. 2019; 381:1918-1928.
Indications & Important Safety Information
Please click here for Full Prescribing Information.
Do you wish to leave this site?